Association ofGBAMutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease-Reference-Cited by-同舟云学术

Association ofGBAMutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease

Published:2016-10-01 Issue:10 Volume:73 Page:1217
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Davis Marie Y.¹,Johnson Catherine O.²,Leverenz James B.³,Weintraub Daniel⁴,Trojanowski John Q.⁵,Chen-Plotkin Alice⁶,Van Deerlin Vivianna M.⁵,Quinn Joseph F.⁷,Chung Kathryn A.⁷,Peterson-Hiller Amie L.⁷,Rosenthal Liana S.⁸,Dawson Ted M.⁹,Albert Marilyn S.¹⁰,Goldman Jennifer G.¹¹,Stebbins Glenn T.¹¹,Bernard Bryan¹¹,Wszolek Zbigniew K.¹²,Ross Owen A.¹³,Dickson Dennis W.¹³,Eidelberg David¹⁴,Mattis Paul J.¹⁴,Niethammer Martin¹⁵,Yearout Dora¹,Hu Shu-Ching¹,Cholerton Brenna A.¹⁶,Smith Megan¹⁷,Mata Ignacio F.¹,Montine Thomas J.¹⁸,Edwards Karen L.¹⁷,Zabetian Cyrus P.¹

Affiliation:

1. Veterans Affairs Puget Sound Health Care System, Seattle, Washington2Department of Neurology, University of Washington School of Medicine, Seattle

2. Department of Neurology, University of Washington School of Medicine, Seattle

3. Lou Ruvo Center for Brain Health, Neurological Institute, Cleveland Clinic, Cleveland, Ohio

4. Department of Psychiatry, University of Pennsylvania, Philadelphia

5. Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia

6. Department of Neurology, University of Pennsylvania, Philadelphia

7. Portland Veterans Affairs Medical Center, Portland, Oregon8Department of Neurology, Oregon Health and Science University, Portland

8. Neurodegeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland10Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland

9. Neurodegeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland10Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland11Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland12Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland

10. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland

11. Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois

12. Department of Neurology, Mayo Clinic, Jacksonville, Florida

13. Department of Neuroscience, Mayo Clinic, Jacksonville, Florida

14. Center for Neurosciences, Feinstein Institute for Medical Research, Manhasset, New York17Department of Neurology, Northwell Health, Manhasset, New York

15. Center for Neurosciences, Feinstein Institute for Medical Research, Manhasset, New York

16. Veterans Affairs Puget Sound Health Care System, Seattle, Washington18Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle

17. Department of Epidemiology, University of California, Irvine, School of Medicine

18. Department of Pathology, University of Washington School of Medicine, Seattle

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicogenetic Characterization of Patients with PD and Heterozygous GBA1 Variants in an Indian Cohort;Movement Disorders;2023-12-20

2. Modeling familial and sporadic Parkinson's disease in small fishes;Development, Growth & Differentiation;2023-12-11

3. Freezing of gait in Parkinson’s disease with glucocerebrosidase mutations: prevalence, clinical correlates and effect on quality of life;Frontiers in Neuroscience;2023-11-28

4. Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study;npj Parkinson's Disease;2023-11-23

5. Cognitive Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease with GBA1 Pathogenic Variants;Movement Disorders;2023-11-02